合計 50 件の最近のインサイダー取引記録が記録されています Cue Biopharma, Inc. (CUE), 内訳は 44 件の買い および 0 件の売り. インサイダー買い総額は $7.56M インサイダー売り総額は RSU アワード.
最近活動のある主要インサイダーには Broadfoot Jill Marie, Kiener Peter A, Morich Frank. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — CUE
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-01-02 |
Broadfoot Jill Marie |
Director |
RSU 付与（制限付株式） |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Kiener Peter A |
Director |
RSU 付与（制限付株式） |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Morich Frank |
Director |
RSU 付与（制限付株式） |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Verheyen Patrick |
Director |
RSU 付与（制限付株式） |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Garzone Pamela |
Director |
RSU 付与（制限付株式） |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Sarraf Pasha |
Director |
RSU 付与（制限付株式） |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2025-12-30 |
Sarraf Pasha |
Director |
情報に基づく買い |
4,229 |
$0.31 |
$1.31K |
4,229 |
| 2025-12-03 |
Sandercock Colin |
SVP, General Counsel |
RSU 付与（制限付株式） |
70,000 |
$0.70 |
$49K |
70,000 |
| 2025-09-29 |
Azam Usman |
Officer |
不明 |
- |
- |
- |
- |
| 2025-09-29 |
Azam Usman |
Chief Executive Officer |
RSU 付与（制限付株式） |
1,875,000 |
$0.72 |
$1.35M |
1,875,000 |
| 2025-09-29 |
Warren Lucinda |
Chief Business Officer |
RSU 付与（制限付株式） |
125,000 |
$0.72 |
$90K |
125,000 |
| 2025-09-29 |
Baker Daniel G. |
Chief Development Officer |
RSU 付与（制限付株式） |
50,000 |
$0.72 |
$36K |
50,000 |
| 2025-09-26 |
Sandercock Colin |
SVP, General Counsel |
RSU 付与（制限付株式） |
30,000 |
$0.70 |
$21K |
30,000 |
| 2025-06-04 |
Broadfoot Jill Marie |
Officer |
不明 |
- |
- |
- |
- |
| 2025-06-04 |
Broadfoot Jill Marie |
Director |
RSU 付与（制限付株式） |
48,800 |
$0.62 |
$30.26K |
48,800 |
| 2025-03-21 |
Passeri Daniel R |
Chief Executive Officer |
RSU 付与（制限付株式） |
450,000 |
$0.99 |
$445.5K |
450,000 |
| 2025-03-21 |
Sandercock Colin |
SVP, General Counsel |
RSU 付与（制限付株式） |
200,000 |
$0.99 |
$198K |
200,000 |
| 2025-03-21 |
Millar Kerri-ann |
Chief Financial Officer |
RSU 付与（制限付株式） |
200,000 |
$0.99 |
$198K |
200,000 |
| 2025-03-21 |
Levisetti Matteo |
Chief Medical Officer |
RSU 付与（制限付株式） |
250,000 |
$0.99 |
$247.5K |
250,000 |
| 2025-03-21 |
Warren Lucinda |
Chief Business Officer |
RSU 付与（制限付株式） |
250,000 |
$0.99 |
$247.5K |
250,000 |
| 2025-03-21 |
Baker Daniel G. |
Chief Development Officer |
RSU 付与（制限付株式） |
100,000 |
$0.99 |
$99K |
100,000 |
| 2025-03-10 |
Sarraf Pasha |
Officer |
不明 |
- |
- |
- |
- |
| 2025-03-10 |
Sarraf Pasha |
Director |
RSU 付与（制限付株式） |
48,800 |
$1.03 |
$50.26K |
48,800 |
| 2025-01-02 |
Driscoll Frederick W |
Director |
RSU 付与（制限付株式） |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Kiener Peter A |
Director |
RSU 付与（制限付株式） |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Morich Frank |
Director |
RSU 付与（制限付株式） |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Verheyen Patrick |
Director |
RSU 付与（制限付株式） |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Garzone Pamela |
Director |
RSU 付与（制限付株式） |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2024-12-16 |
Passeri Daniel R |
Chief Executive Officer |
情報に基づく買い |
30,000 |
$1.03 |
$30.9K |
164,578 |
| 2024-11-25 |
Baker Daniel G. |
Officer |
不明 |
- |
- |
- |
- |
| 2024-11-25 |
Baker Daniel G. |
Chief Development Officer |
RSU 付与（制限付株式） |
200,000 |
$1.06 |
$212K |
200,000 |
| 2024-09-03 |
Warren Lucinda |
Officer |
不明 |
- |
- |
- |
- |
| 2024-09-03 |
Warren Lucinda |
Chief Business Officer |
RSU 付与（制限付株式） |
350,000 |
$0.66 |
$231K |
350,000 |
| 2024-06-05 |
Fox Michael J |
Director |
不明 |
- |
- |
- |
100,000 |
| 2024-06-05 |
Fox Michael J |
Director |
RSU 付与（制限付株式） |
48,800 |
$1.65 |
$80.52K |
48,800 |
| 2024-06-05 |
Sandercock Colin |
SVP, General Counsel |
RSU 付与（制限付株式） |
60,000 |
$1.65 |
$99K |
60,000 |
| 2024-06-05 |
Millar Kerri-ann |
Chief Financial Officer |
RSU 付与（制限付株式） |
60,000 |
$1.65 |
$99K |
60,000 |
| 2024-06-05 |
Suri Anish |
President and CSO |
RSU 付与（制限付株式） |
150,000 |
$1.65 |
$247.5K |
150,000 |
| 2024-06-05 |
Levisetti Matteo |
Chief Medical Officer |
RSU 付与（制限付株式） |
125,000 |
$1.65 |
$206.25K |
125,000 |
| 2024-03-06 |
Passeri Daniel R |
Chief Executive Officer |
RSU 付与（制限付株式） |
400,000 |
$1.94 |
$776K |
400,000 |
| 2024-03-06 |
Sandercock Colin |
SVP, General Counsel |
RSU 付与（制限付株式） |
175,000 |
$1.94 |
$339.5K |
175,000 |
| 2024-03-06 |
Millar Kerri-ann |
Chief Financial Officer |
RSU 付与（制限付株式） |
250,000 |
$1.94 |
$485K |
250,000 |
| 2024-03-06 |
Suri Anish |
President and CSO |
RSU 付与（制限付株式） |
300,000 |
$1.94 |
$582K |
300,000 |
| 2024-03-06 |
Levisetti Matteo |
Chief Medical Officer |
RSU 付与（制限付株式） |
260,000 |
$1.94 |
$504.4K |
260,000 |
| 2024-02-20 |
Levisetti Matteo |
Chief Medical Officer |
RSU 付与（制限付株式） |
25,000 |
$3.36 |
$84K |
25,000 |
| 2024-01-02 |
Driscoll Frederick W |
Director |
RSU 付与（制限付株式） |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Kiener Peter A |
Director |
RSU 付与（制限付株式） |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Morich Frank |
Director |
RSU 付与（制限付株式） |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Verheyen Patrick |
Director |
RSU 付与（制限付株式） |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Garzone Pamela |
Director |
RSU 付与（制限付株式） |
24,400 |
$2.78 |
$67.83K |
24,400 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
